Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced the initiation of Part B of ...

peripheral schisis in one or both eyes, and (v) complications (vitreous haemorrhage or retinal detachment). RS1 mutations were categorised depending on (i) whether they affected a conserved amino acid ...

People who develop macular degeneration often begin experiencing symptoms after 50 years old, but symptoms can happen earlier or later depending on conditions and risk factors. Share on Pinterest ...

A retinal tear is a common age-related eye condition. It causes eye floaters and flashes of light and may lead to more severe vision problems. On its own, a torn retina will not damage your eyesight.

XLRS is characterized by schisis, or abnormal splitting of retinal layers, which causes impaired visual acuity that is not correctable with glasses and ultimately leads to blindness. Approximately ...

Age-related macular degeneration (AMD) has three stages: early, intermediate, and late stage. Vision loss usually happens in the last stage of AMD. However, not everyone with AMD progresses through ...

XLRS is a monogenic X-linked retinal disorder caused by mutations in the RS1 gene, which encodes retinoschisin, a protein secreted predominantly by photoreceptors. This protein localizes to the ...